HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Primary Care & Family Medicine
Cohort
Permanent night shift work associated with increased chronic kidney disease risk in UK Biobank participants
Permanent night shift work linked to kidney disease risk
This prospective cohort study of UK Biobank participants found an association between permanent night shift work and increased risk of incid…
Working permanent night shifts may increase your risk of developing chronic kidney disease, according to a large study of UK Biobank partici…
Frontiers
Apr 30, 2026
Allergy & Immunology
Sys. Review
Narrative review discusses renal risks in inflammatory bowel disease patients
Kidney risks for people with inflammatory bowel disease remain unclear and need more study
This narrative review examines renal complications in individuals with inflammatory bowel disease. The authors highlight that causal pathway…
People with inflammatory bowel disease face kidney risks, but current evidence relies on animal studies and lacks human proof.
Frontiers
Apr 29, 2026
Cardiology
Sys. Review
Narrative review examines multimorbidity impact on sepsis morbidity and mortality outcomes
Sepsis Risk Skyrockets When You Have Multiple Chronic Conditions
This narrative review synthesizes evidence regarding sepsis in patients with multimorbidity including type 2 diabetes and heart failure. Aut…
Common chronic diseases like diabetes and heart failure create hidden traps that make sepsis much harder to fight and treat.
Frontiers
Apr 29, 2026
Nutrition & Obesity Medicine
Cohort
Higher TyG index linked to increased renal function progression risk in patients with CKD stages 3–4
High TyG Index Signals Faster Kidney Decline In Advanced Disease
This multicenter retrospective cohort study evaluated 53,607 patients with CKD stages 3–4. Each 1-unit increase in the baseline TyG index wa…
A simple blood test number reveals who is at highest risk for rapid kidney failure among thousands of patients.
Frontiers
Apr 28, 2026
Nephrology
Meta-analysis
Individual-participant data meta-analysis shows blood-pressure lowering reduces cardiovascular risk in CKD and non-CKD populations
Blood pressure drugs protect kidneys and hearts across all stages
This individual-participant data meta-analysis pooled results from 46 randomised trials involving 285,124 participants to evaluate blood-pre…
Lowering blood pressure protects the heart and kidneys across all stages of kidney disease, but the benefit is weaker in patients who also h…
Apr 27, 2026
Nephrology
Observational study links cutaneous microvascular function to chronic kidney disease severity
Skin blood flow changes may link to kidney disease
This observational study of 150 participants with chronic kidney disease (eGFR <90 mL/min/1.73 m2) investigated the relationship between cut…
New observations suggest that changes in skin blood flow patterns may be linked to how well your kidneys are functioning.
medRxiv
Apr 27, 2026
Neurology
RCT
Oral beraprost extends median survival in dogs with IRIS stage 2 chronic kidney disease compared to historical controls.
Beraprost Adds Years to Dogs’ Lives with Early Kidney Disease
This prospective clinical study evaluated oral beraprost in dogs with naturally occurring IRIS stage 2 chronic kidney disease. The treatment…
Dogs with early kidney disease who took a certain medication lived more than five times longer than those who didn’t — and vets are taking n…
Frontiers
Apr 25, 2026
Diabetes & Endocrinology
Meta-analysis
Meta-analysis of dapagliflozin for renal outcomes in type 2 diabetes and CKD
SGLT2 inhibitors lower kidney failure risk in type 2 diabetes patients
This systematic review and meta-analysis of 10 studies synthesized evidence on dapagliflozin for renal outcomes in patients with type 2 diab…
A review of ten studies shows these drugs reduce kidney failure risk in people with type 2 diabetes and kidney disease.
Frontiers
Apr 24, 2026
Drug Pipeline
Sys. Review
Narrative review supports SGLT-2i use in cardiovascular-kidney-metabolic syndrome
New Treatment Shifts How We Fight Heart, Kidney, and Diabetes Damage
This narrative review summarizes evidence on SGLT-2 inhibitors for patients with stages 2–4 cardiovascular-kidney-metabolic syndrome. The au…
Maria, 58, has type 2 diabetes and high blood pressure.
Frontiers
Apr 24, 2026
Nephrology
Meta-analysis
Systematic review and meta-analysis shows dapagliflozin increases hemoglobin in chronic kidney disease patients.
Common Diabetes Drug May Help Anemia in Kidney Disease
This systematic review and meta-analysis evaluated dapagliflozin in chronic kidney disease (CKD) patients with anemia. The analysis pooled d…
This study suggests a common diabetes drug could treat anemia in kidney patients without the risks of current options.
Apr 24, 2026
Nephrology
Cross-sectional study links declining nephron number to CKD stage in diabetic nephropathy
Kidney Filters Fail One by One in Diabetes
This cross-sectional observational study abstract examined 105 patients with biopsy-proven diabetic nephropathy and overt proteinuria, strat…
Even when kidneys look okay, their filters are quietly failing in people with diabetes, a new study shows — and that could explain why damag…
medRxiv
Apr 24, 2026
Nephrology
RCT
Pilot RCT tests digital inclusion intervention for adults with chronic kidney disease.
Free Tablets and Training Bridge the Digital Health Gap
This pilot randomized controlled trial enrolled 40 digitally excluded adults with chronic kidney disease to test a tablet loan and digital l…
Giving devices and training makes digital health work for people who usually get left behind.
Apr 23, 2026